OvuGel is a veterinary medicine used to synchronise ovulation in weaned sows (sows whose piglets have been taken away) for reproduction to enable artificial insemination. Because ovulation occurs as a timed response to treatment with Ovugel, a timed insemination program can therefore be used to breed sows.
OvuGel contains the active substance triptorelin (as acetate), which is a synthetic analogue of gonadotropin releasing hormone (GnRH).
OvuGel : EPAR - Medicine overview (DOCX/117.34 KB)
First published: 07/05/2021
|Agency product number||
|International non-proprietary name (INN) or common name||
Pigs (sows for reproduction)
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
|Date of issue of marketing authorisation valid throughout the European Union||
Magny Vernois 70200
10/11/2020 OvuGel - EMEA/V/C/005219 -
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pituitary and hypothalamic hormones and analogues
For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.